Alector, Inc. (27)
Browse by Contract Category
Contracts
-
Retention Letter Agreement, dated March 23, 2021, among Mr. Calvin Yu and Alector, Inc
(Filed With SEC on March 26, 2021)
-
Description of securities of the Registrant
(Filed With SEC on February 25, 2021)
-
Equity Distribution Agreement, dated May 13, 2020, by and among Alector, Inc., Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC
(Filed With SEC on May 13, 2020)
-
2019 Collaboration Agreement between the Registrant and Adimab, LLC, dated August 16, 2019
(Filed With SEC on November 12, 2019)
-
Lease between the Registrant and HCP Oyster Point III, LLC, dated June 27, 2018
(Filed With SEC on January 7, 2019)
-
Outside Director Compensation Policy
(Filed With SEC on March 24, 2020)
-
Description of securities of the Registrant
(Filed With SEC on March 24, 2020)
-
Underwriting Agreement, dated as of January 29, 2020, among the Registrant, Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, BofA Securities, Inc., and Cowen and Company, LLC,...
(Filed With SEC on February 4, 2020)
-
Form of Underwriting Agreement, including Form of Lock-up Agreement
(Filed With SEC on January 27, 2020)
-
Confirmatory Offer Letter between the Registrant and Robert Paul, M.D., Ph.D
(Filed With SEC on January 29, 2019)
-
Confirmatory Offer Letter between the Registrant and Arnon Rosenthal, Ph.D
(Filed With SEC on January 29, 2019)
-
Confirmatory Offer Letter between the Registrant and Robert King, Ph.D
(Filed With SEC on January 29, 2019)
-
Confirmatory Offer Letter between the Registrant and Sabah Oney, Ph.D
(Filed With SEC on January 29, 2019)
-
Confirmatory Offer Letter between the Registrant and Calvin Yu
(Filed With SEC on January 29, 2019)
-
2019 Equity Incentive Plan and forms of agreements thereunder, to be in effect upon the completion of this offering
(Filed With SEC on January 7, 2019)
-
Form of Underwriting Agreement, including Form of Lock-up Agreement
(Filed With SEC on January 7, 2019)
-
Co-Development and Option Agreement between the Registrant and AbbVie Biotechnology, Ltd., dated October 16, 2017
(Filed With SEC on January 7, 2019)
-
Sublease between the Registrant and CytomX Therapeutics, Inc., dated April 25, 2016
(Filed With SEC on January 7, 2019)
-
Amended and Restated Registration Rights Agreement among the Registrant and certain of its stockholders, dated April 26, 2018
(Filed With SEC on January 7, 2019)
-
2019 Employee Stock Purchase Plan, to be in effect upon the completion of this offering
(Filed With SEC on January 7, 2019)
-
Specimen common stock certificate of the Registrant
(Filed With SEC on January 7, 2019)
-
Form of Indemnification Agreement between the Registrant and each of its directors and executive officers
(Filed With SEC on January 7, 2019)
-
Third Amended and Restated Collaboration Agreement between the Registrant and Adimab, dated September 19, 2016, as amended
(Filed With SEC on January 7, 2019)
-
Form of Change in Control and Severance Agreement between the Registrant and certain of its executive officers
(Filed With SEC on January 7, 2019)
-
2017 Stock Option and Grant Plan, as amended, and forms of agreement thereunder
(Filed With SEC on January 7, 2019)
-
Executive Incentive Compensation Plan
(Filed With SEC on January 7, 2019)
-
Outside Director Compensation Policy
(Filed With SEC on January 7, 2019)